Crossmark

Morbus Waldenström: Neuer BTK-Inhibitor besser verträglich?

Crossref DOI link: https://doi.org/10.1007/s15015-020-2510-3

Published Online: 2020-09-04

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Borchers, Moritz
License Information

Text and Data Mining valid from 2020-09-01

Version of Record valid from 2020-09-01
More Information

Article History

First Online: 4 September 2020

Free to read: This content has been made available to all.